Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. coronavirus
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Coronavirus Articles & Analysis

252 news found

BioZyme Launches VitaFerm Sure Start Gel

BioZyme Launches VitaFerm Sure Start Gel

BioZyme’s mission is to provide an undeniable positive impact on the health and wellness of the animals it serves. Therefore, BioZyme and its staff continually research and create products to help animals and maximize efficiencies for producers. With our mission and commitment to care that comes full circle in mind, we are excited to introduce VitaFerm® Sure Start Gel. VitaFerm Sure ...

ByBioZyme Incorporated


Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

All testing involving viral particles will be done and handled safely by trained professionals at the FAU laboratories. Why Alertgy's Coronavirus Detection Technology is So Groundbreaking The current COVID-19 pandemic has highlighted the need for rapid development of reliable tests for emerging dangerous pathogens, especially those that are ...

ByAlertgy


(Viral) Vaccine Manufacturing

(Viral) Vaccine Manufacturing

Viral Vaccine Manufacturing to control pandemics: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has created a global public health crisis. ...

ByNuvonis


CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

Dr Richard Hatchett, CEO of CEPI, said: “Coronaviruses have now proven their pandemic potential with devastating consequences, and COVID-19 won’t be the last coronavirus to threaten humanity. That’s why CEPI’s ambitious programme to develop globally accessible vaccines that protect against a broad range of coronaviruses – before those pathogens ...

ByNEC OncoImmunity AS 


Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) ...

ByKephera Diagnostics, LLC


Sensible Medical ReDS Lung Fluid Monitor to Help COVID-19 Patients in Italy, US and Other Countries

Sensible Medical ReDS Lung Fluid Monitor to Help COVID-19 Patients in Italy, US and Other Countries

Hospitals treating COVID-19 patients are looking to use the radar-based technology, previously used in heart-failure patients, to monitor lungs of coronavirus patients. Sensible Medical has recently received urgent requests from hospitals around the world for its ReDS monitors systems to improve monitoring, treatment and resource use for COVID-19 patients. ...

BySensible Medical Innovations Ltd.


New patent application published!

New patent application published!

This application was made after the surprising observation that Atelerix’s hydrogel-encapsulation technology (in the form of SwabReady™) was able to extend the shelf life of free Coronavirus samples when stored at room temperature. Whilst in conventional viral transport medium viral function fell to non-detectable levels after 3 days, SwabReady™ extended this to ...

ByAtelerix Ltd


Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Prior studies indicate that high levels of IL-6 serve as an early indication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced hyperinflammation, disease severity, and multiorgan ...

ByBluejay Diagnostics, Inc.


Mutations in the SARS-CoV-2 spike protein gene

Mutations in the SARS-CoV-2 spike protein gene

Immundiagnostik's respiratroy PCR assays MutaPLEX® Coronavirus (KG1926), MutaPLEX® RespiraScreen 1 (KG1927), MutaPLEX® RespiraScreen 2 DIFF (KG1928) and MutaPLEX® Coronavirus 4G (KG1936) were screened for the spike protein mutations in the following viral variants: [Omicron] (BA.1, BA.2, BA.4, BA.5) [Omicron] (BA.3, BA.2 + L452X) [Alpha], ...

ByImmundiagnostik AG


Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics

Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics

Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Wednesday, May 4, 2022. In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. ...

ByInfant Bacterial Therapeutics AB


Positive FDA Guidance For Covid-19 Clinical Program

Positive FDA Guidance For Covid-19 Clinical Program

Food and Drug Administrations (‘FDA’) for development of its lead antiviral drug BIT225 as a potential treatment of Coronavirus Disease 2019 (COVID-19) infection in adults. The FDA’s guidance was received in written response to Biotron’s pre-IND briefing package and request in March 2022, which included an overview of preclinical and (HIV) clinical ...

ByBiotron Limited


Role of oxygen generator in the epidemic period of coronavirus disease

Role of oxygen generator in the epidemic period of coronavirus disease

The oxygen generator can support the treatment of severe patients with coronavirus disease. In the long run, it can also help treat childhood pneumonia (one of the main causes of death in children under the age of five) and hypooxia (an important sign of death). Respiratory support in patients with coronavirus disease About 15% of patients with ...

ByKunshan Dynmed Medical Technology Co,. Ltd.


Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

The epidemic caused by the Novel Coronavirus has had a significant impact on human health and economic development and has brought severe challenges to global public health security. ...

ByInsilico Medicine


Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer

Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer

Important factors that could cause actual results, conditions and events to differ materially from those indicated in the forward-looking statements include, among others, the following: uncertainties associated with the coronavirus (COVID-19) pandemic, including its possible effects on our operations, and the demand for our products; our ability to successfully and profitably ...

ByMDxHealth


Covid-19 or Seasonal Allergy: How to differentiate?

Covid-19 or Seasonal Allergy: How to differentiate?

It's also important to wash your mask after each use since a mask might carry pollen particles. As the coronavirus disease (COVID-19) continues to evolve and symptoms become milder, knowing the important differences between these two illnesses, allows you to take preventive measures that can help you and your environment to stay healthy. ...

ByHYCOR Biomedical


Report On Activities For The Quarter Ended 31 March 2022

Report On Activities For The Quarter Ended 31 March 2022

Submitted a proposal to the USA Food and Drug Administration to conduct a human clinical trial to assess the efficacy of BIT225 for the treatment of COVID-19 under the Coronavirus Treatment Acceleration Program, a special emergency program for potential coronavirus therapies. ...

ByBiotron Limited


Flottweg posts record figures for 2021

Flottweg posts record figures for 2021

CFO Peter Frankfurter is very pleased with the final figures: "Although Flottweg has faced various difficulties, such as the challenges posed by the coronavirus pandemic and global supply shortages, we have managed to develop further within the framework of Strategy 2025. ...

ByFlottweg SE


CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants

CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants

As part of this plan CEPI is working to strengthen our defences against COVID-19 and reduce the risk of future coronavirus pandemics, by optimizing our current vaccines, addressing variants of concern, developing next-generation COVID-19 vaccines, and initiating the development of broadly protective or universal coronavirus ...

ByVaxxinit


Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

Strong preclinical evidence of universal efficacy of zapnometinib against coronavirus variants of concernProf. Planz will continue to serve Atriva as Chairman of the Scientific Advisory Board The findings underscore the importance of new therapeutic approaches such as zapnometinib, which can maintain potent efficacy against all coronavirus strains, including ...

ByAtriva Therapeutics GmbH


Postponement Notice of HanoiPlas

Postponement Notice of HanoiPlas

Given the ongoing uncertainty surrounding the coronavirus variant, travel restrictions and quarantine requirements for international travelers, it has become extremely challenging for exhibitors and visitors to plan their participation with confidence and certainty. ...

ByChan Chao International Co., Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT